NCT00557739View on ClinicalTrials.gov

Study of CRx-191 to Assess Activity in Plaque Psoriasis

PHASE2CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions

Plaque Psoriasis

Interventions

DRUG

mometasone furoate

Topical 0.1% mometasone furoate

DRUG

nortriptyline HCl

Topical 0.05% or 0.1% nortriptyline HCl

DRUG

Vehicle (placebo)

Topical placebo

Trial Locations (1)

Unknown

bioskin GmbH, Berlin

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

Bioskin GmbH

INDUSTRY

lead

Zalicus

INDUSTRY

NCT00557739 - Study of CRx-191 to Assess Activity in Plaque Psoriasis | Biotech Hunter | Biotech Hunter